SE8002545L - Arylsubstituerade furaner och sett for framstellning derav - Google Patents
Arylsubstituerade furaner och sett for framstellning deravInfo
- Publication number
- SE8002545L SE8002545L SE8002545A SE8002545A SE8002545L SE 8002545 L SE8002545 L SE 8002545L SE 8002545 A SE8002545 A SE 8002545A SE 8002545 A SE8002545 A SE 8002545A SE 8002545 L SE8002545 L SE 8002545L
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- furnaces
- hydrogen
- image
- disclosed
- Prior art date
Links
- 150000002240 furans Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 125000004442 acylamino group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000674 adrenergic antagonist Substances 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000005805 dimethoxy phenyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792914166 DE2914166A1 (de) | 1979-04-07 | 1979-04-07 | Arylsubstituierte furane und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8002545L true SE8002545L (sv) | 1980-10-08 |
Family
ID=6067779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8002545A SE8002545L (sv) | 1979-04-07 | 1980-04-02 | Arylsubstituerade furaner och sett for framstellning derav |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4265903A (fr) |
| JP (1) | JPS55167284A (fr) |
| AT (1) | AT374193B (fr) |
| AU (1) | AU536861B2 (fr) |
| BE (1) | BE882629A (fr) |
| CA (1) | CA1152087A (fr) |
| DE (1) | DE2914166A1 (fr) |
| DK (1) | DK140780A (fr) |
| FR (1) | FR2453167A1 (fr) |
| GB (1) | GB2048259B (fr) |
| IT (1) | IT1141266B (fr) |
| NL (1) | NL8001893A (fr) |
| SE (1) | SE8002545L (fr) |
| ZA (1) | ZA801237B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI76551C (fi) | 1980-11-06 | 1988-11-10 | Sandoz Ag | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat. |
| US6818660B2 (en) | 1996-04-09 | 2004-11-16 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
| EP0901459B1 (fr) | 1996-04-09 | 2005-06-29 | Nps Pharmaceuticals, Inc. | Composes calcilytiques |
| TW483881B (en) | 1996-12-03 | 2002-04-21 | Nps Pharma Inc | Calcilytic compounds |
| US7202261B2 (en) | 1996-12-03 | 2007-04-10 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
| EP2365746B1 (fr) * | 2008-11-04 | 2014-07-16 | Wellstat Therapeutics Corporation | Synthèse d'acides (phénylalkyloxy)phényl-oxobutanoïques |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1047927A (en) * | 1964-03-09 | 1966-11-09 | Ici Ltd | Alkanolamine derivatives |
| CA956632A (en) * | 1969-05-16 | 1974-10-22 | Yoshitomi Pharmaceutical Industries | Phenoxy-aminopropanol derivatives |
| US4115409A (en) * | 1975-12-05 | 1978-09-19 | Imperial Chemical Industries Limited | Alkanolamine derivatives |
-
1979
- 1979-04-07 DE DE19792914166 patent/DE2914166A1/de not_active Withdrawn
-
1980
- 1980-03-04 ZA ZA00801237A patent/ZA801237B/xx unknown
- 1980-03-31 JP JP4055180A patent/JPS55167284A/ja active Pending
- 1980-03-31 NL NL8001893A patent/NL8001893A/nl not_active Application Discontinuation
- 1980-03-31 US US06/135,954 patent/US4265903A/en not_active Expired - Lifetime
- 1980-04-01 DK DK140780A patent/DK140780A/da not_active Application Discontinuation
- 1980-04-01 IT IT8021089A patent/IT1141266B/it active
- 1980-04-02 AU AU57090/80A patent/AU536861B2/en not_active Ceased
- 1980-04-02 SE SE8002545A patent/SE8002545L/xx not_active Application Discontinuation
- 1980-04-03 BE BE0/200114A patent/BE882629A/fr not_active IP Right Cessation
- 1980-04-03 GB GB8011334A patent/GB2048259B/en not_active Expired
- 1980-04-04 FR FR8007673A patent/FR2453167A1/fr active Granted
- 1980-04-04 AT AT0187580A patent/AT374193B/de not_active IP Right Cessation
- 1980-04-08 CA CA000349334A patent/CA1152087A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU5709080A (en) | 1980-10-09 |
| GB2048259A (en) | 1980-12-10 |
| CA1152087A (fr) | 1983-08-16 |
| US4265903A (en) | 1981-05-05 |
| DK140780A (da) | 1980-10-08 |
| IT8021089A0 (it) | 1980-04-01 |
| GB2048259B (en) | 1983-02-16 |
| AU536861B2 (en) | 1984-05-24 |
| JPS55167284A (en) | 1980-12-26 |
| AT374193B (de) | 1984-03-26 |
| FR2453167B1 (fr) | 1983-12-02 |
| ZA801237B (en) | 1981-03-25 |
| DE2914166A1 (de) | 1980-10-23 |
| ATA187580A (de) | 1983-08-15 |
| IT1141266B (it) | 1986-10-01 |
| NL8001893A (nl) | 1980-10-09 |
| BE882629A (fr) | 1980-10-03 |
| FR2453167A1 (fr) | 1980-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK160877C (da) | Fremgangsmaade til fremstilling af 2-penemforbindelser | |
| ATE132495T1 (de) | Piperazinderivate | |
| ATE17249T1 (de) | 9-(2-(3-indolyl)aethyl)-1-oxa-4,9diazaspiro(5.5)undecan-3-one. | |
| ES8203845A1 (es) | Procedimiento para preparar derivados de piridoxina | |
| ES8507090A1 (es) | Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas | |
| ES473925A1 (es) | Un procedimiento para la preparacion de un oligopeptido | |
| SE8002545L (sv) | Arylsubstituerade furaner och sett for framstellning derav | |
| DK501480A (da) | Fremgangsmaade til fremstilling af substituerede 2-phenylamino-imidazoliner-(2). | |
| ES8202003A1 (es) | Un procedimiento para la preparacion de derivados de ergoli-na | |
| NO792389L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylamino-imidazolin-derivater | |
| NO157655C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazolderivater. | |
| JPS554392A (en) | Imidazole derivative and medical composition | |
| SE8703623L (sv) | Komposition innefattande ett stannoreduceringsmedel och n-substituerade iminodiettiksyror | |
| DK428087A (da) | Dihydropyridin-5-phosphonsyre-cyclopropylenester | |
| ZA8312B (en) | Substituted 1-benzoyl-2-phenyliminiomidazolidine derivatives | |
| ZA807790B (en) | 2-phenylamino-imidazolines-(2),compositions thereof and process for the preparation thereof | |
| CH653840GA3 (en) | Process for protecting keratin-containing materials from attack by keratin-eating insects and 5-phenylcarbamoylbarbituric acid compounds | |
| ES471596A1 (es) | Procedimiento para preparar alfa-halometil derivados de al- fa-amino acidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8002545-5 Format of ref document f/p: F |